A single premarket notification links Borze, Inc. to a laser device family in FDA records. The submission was received September 1, 2026, and decided October 30, 2026, as substantially equivalent under the traditional 510(k) route, with a summary rather than a full statement. The record places the device in the General and Plastic Surgery review panel and classifies it as a class 2 powered laser surgical instrument. [1][2][3]

The applicant and the filing

Borze, Inc. appears as the applicant on K263063, with Rex Howard Frazier listed as contact and a Boise, Idaho address on the submission. The FDA correspondence for the same filing is addressed to Borze, Inc. care of Long Yang, general manager of Shenzhen Hlongmed Biotech Co., Ltd., in Shenzhen, China. The two addresses serve different roles in the record and neither is documented as a corporate headquarters. [1][2][6]

The decision is recorded as Substantially Equivalent (SESE), with a decision description of Substantially Equivalent, a Traditional clearance type, no third-party review, and no combination product designation. The summary document is listed as the statement or summary type. [1][3][7]

Documented device and models

The cleared name is B`orze Inc Laser Family (Sorren/Adonis). The summary identifies the product as a diode laser therapy device and lists models Sorren and Adonis ST-AR L2, alongside product names including Medical Diode Laser and LaserPro 810, 940 and 980 Diode Laser Systems. [2]

Regulatory listings describe the device as a powered laser surgical instrument for use in general and plastic surgery under 21 CFR 878.4810, product code GEX, device class 2. The advisory committee and review panel are both recorded as General and Plastic Surgery. [1][3][9]

Timeline and collection context

The submission was received September 1, 2026, and decided October 30, 2026. The FDA premarket notification listing shows the same received and decision dates for K263063, with the page last updated November 16, 2026. [3][6]

In the supplied collection as of November 20, 2026, one linked record exists, all under the 510(k) pathway, and the decision counts show one SESE decision. The smaller record sample likewise contains one record, K263063, with a sample decision count of one SESE. These are counts of the supplied filings, not measures of company sales, total portfolio or safety performance. [1]

Company identity and published material

Borze, Inc.'s own website, published as borzeinc.com, describes B`ORZE Inc., America as a producer of colposcopes and lists products including the HD INTTELIO and DVC 20000 HD digital video colposcopes and CTG/fetal monitor lines. The site gives a Boise, Idaho address and an [email protected] email contact. [8]

The website material and the laser filing describe different product lines, and the public documents do not document a parent, subsidiary or brand relationship between them beyond the shared company name. Any ownership structure or manufacturing relationship remains unknown from these records. [2][8]